P Chidambaram slams 'shameless RSS' for dragging economy into 'negative growth territory'

P Chidambaram slams 'shameless RSS' for dragging economy into 'negative growth territory'

Sanjay JogUpdated: Saturday, May 23, 2020, 11:16 AM IST
article-image
P Chidambaram and Nirmala Sitharaman | File Image

Veteran Congress leader and former union finance ministe P Chidambaram on Saturday said RSS should be ashamed of how the government has dragged the economy into negative growth territory.

"Governor RBI says demand has collapsed, growth in 2020-21 headed toward negative territory. Why is he then infusing more liquidity?" said Chidambaram in his tweet. He reacted after RBI on Friday offered first official acceptance that GDP growth will slip into negative territory this year. RBI said it will be due to collapse in demand because of a slide in private consumption following the Coronavirus pandemic.

Chidambaram said the RBI Governor should bluntly tell the government ‘Do your duty, take fiscal measures.'

"Even after RBI’s statement, is the Government/FM lauding themselves for a package that has fiscal stimulus of less than 1% of GDP?" questioned Chidambaram.

RECENT STORIES

Preity Zinta Beats ₹10-Crore Tax Charge, ITAT Mumbai Rules In Her Favour After Major Reassessment...

Preity Zinta Beats ₹10-Crore Tax Charge, ITAT Mumbai Rules In Her Favour After Major Reassessment...

Bajaj Auto Reports 1% Dip In Domestic Two-Wheeler Sales At 2,02,510 Units In November

Bajaj Auto Reports 1% Dip In Domestic Two-Wheeler Sales At 2,02,510 Units In November

'Inflation Set To Remain Below Target For The Foreseeable Future, RBI Will Cut Rates By 25 Bp During...

'Inflation Set To Remain Below Target For The Foreseeable Future, RBI Will Cut Rates By 25 Bp During...

Silver Futures Touch Record Highs By ₹3,668 To ₹1,78,649 Per Kilogram, Gold To ₹1,30,550,...

Silver Futures Touch Record Highs By ₹3,668 To ₹1,78,649 Per Kilogram, Gold To ₹1,30,550,...

Drug Maker Lupin Receives Approval From The US Health Regulator For A Biosimilar Indicated For...

Drug Maker Lupin Receives Approval From The US Health Regulator For A Biosimilar Indicated For...